PMID- 12377860 OWN - NLM STAT- MEDLINE DCOM- 20021122 LR - 20190514 IS - 0012-3692 (Print) IS - 0012-3692 (Linking) VI - 122 IP - 4 DP - 2002 Oct TI - Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon. PG - 1322-32 AB - BACKGROUND: Growing evidence suggests that no-reflow reperfusion after direct percutaneous coronary intervention (d-PCI) is associated with an unfavorable clinical outcome. The purpose of this study was to evaluate whether prerevascularization angiographic morphologic features of infarct-related arteries (IRAs) and timely reperfusion could convey information on slow-flow (Thrombolysis In Myocardial Infarction [TIMI] 2 flow) or no-reflow (TIMI grade < or = 1 flow) reperfusion after d-PCI. METHODS AND RESULTS: Between May 1993 and September 2000, d-PCI was performed in 794 consecutive patients with acute myocardial infarction. Coronary blood flow failed to normalize in 120 patients (15.1%). The incidence of failure to achieve TIMI 3 flow in the IRAs was significantly higher in patients with vs those without the following distinctive prerevascularization angiographic morphologic features: cutoff pattern of occlusion in the IRA (52.4% vs 10.3%, p < 0.001), accumulated thrombus (> 5 mm) proximal to the occlusion (37.5% vs 3.4%, p < 0.001), presence of floating thrombus (66.7% vs 12.7%, p < 0.001), persistent dye stasis distal to the obstruction (51.9% vs 13.8%, p < 0.001), reference lumen diameter (RLD) of the IRA > or = 4 mm (46.3% vs 9.6%, p < 0.001), and incomplete obstruction with presence of accumulated thrombus more than three times the RLD of the IRA (51.7% vs 3.9, p < 0.0001). Each of these six angiographic morphologic features indicated "high-burden thrombus formation." Multiple stepwise logistic regression analysis demonstrated that each of six angiographic morphologic features was an independent predictor of combined slow-flow and no-reflow phenomenon in the IRAs after d-PCI (p < 0.05). In contrast, early reperfusion time (< 240 min, p = 0.0017), prerevascularization TIMI flow grade > or = 2 (p = 0.0006), and the taper pattern of occlusion in the IRA (p = 0.0284) were independent predictors of freedom from slow-flow or no-reflow phenomenon in the IRAs after d-PCI. The 30-day overall mortality was 8.7% (69 of 794 patients). The 30-day mortality was significantly higher in patients with combined slow-flow and no-reflow phenomenon than in patients with normal coronary blood flow after d-PCI (27.5% vs 5.3%, p < 0.001). CONCLUSIONS: Early reperfusion reduces the incidence of slow-flow or no-reflow phenomenon in the IRA and overall 30-day mortality. The specific angiographic morphologic features in the IRAs can be used as a simple and efficacious method to predict slow-flow or no-reflow phenomenon. These findings provide apparently clinically useful information for the selection of patients who are potential candidates for subsequent prepercutaneous coronary intervention adjunctive therapy. FAU - Yip, Hon-Kan AU - Yip HK AD - Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, 123 Ta Pei Road, Niao Sung Hsiang, Kaohsiung Hsien 83301, Taiwan, ROC. FAU - Chen, Mien-Cheng AU - Chen MC FAU - Chang, Hsueh-Wen AU - Chang HW FAU - Hang, Chi-Ling AU - Hang CL FAU - Hsieh, Yuan-Kai AU - Hsieh YK FAU - Fang, Chih-Yuan AU - Fang CY FAU - Wu, Chiung-Jen AU - Wu CJ LA - eng PT - Comparative Study PT - Journal Article PL - United States TA - Chest JT - Chest JID - 0231335 SB - IM MH - Adult MH - Aged MH - Angioplasty, Balloon, Coronary/adverse effects/*methods/mortality MH - Coronary Angiography/*methods MH - Coronary Vessels/*pathology MH - Female MH - Humans MH - Male MH - Middle Aged MH - Monitoring, Physiologic MH - Myocardial Infarction/*diagnostic imaging/mortality/*therapy MH - Postoperative Period MH - Predictive Value of Tests MH - Probability MH - Retrospective Studies MH - Sensitivity and Specificity MH - Statistics, Nonparametric MH - Survival Analysis MH - Thrombolytic Therapy/adverse effects/*methods/mortality MH - Time Factors MH - Treatment Outcome MH - Vascular Patency/*physiology EDAT- 2002/10/16 04:00 MHDA- 2002/11/26 04:00 CRDT- 2002/10/16 04:00 PHST- 2002/10/16 04:00 [pubmed] PHST- 2002/11/26 04:00 [medline] PHST- 2002/10/16 04:00 [entrez] AID - S0012-3692(15)37802-8 [pii] AID - 10.1378/chest.122.4.1322 [doi] PST - ppublish SO - Chest. 2002 Oct;122(4):1322-32. doi: 10.1378/chest.122.4.1322.